Showing results (1481-1490 of 1,586) with videos related to

Sort By:
Pageof 159
Journal of Oncology Practice|October 15, 2015
ReCAP: Impact of Multidisciplinary Care on Processes of Cancer Care: A Multi-Institutional StudyEberechukwu Onukwugha, Nicholas J Petrelli, Kathleen M Castro, et al.
Hepatology (Baltimore, Md.)|November 29, 2020
Immunosuppressive Drug-Resistant Armored T-Cell Receptor T Cells for Immune Therapy of HCC in Liver Transplant PatientsMorteza Hafezi, Meiyin Lin, Adeline Chia, et al.
Archives of Gerontology and Geriatrics|January 21, 2021
Predictors for development of critical illness amongst older adults with COVID-19: Beyond age to age-associated factorsJun Pei Lim, Kristabella Yu Han Low, Nicole Jia Jing Lin, et al.
The British Journal of Dermatology|August 14, 2019
Genetic alterations in primary melanoma in TaiwanY-S Sheen, K-T Tan, K-P Tse, et al.
The British Journal of Dermatology|October 8, 2017
Development of an international core outcome set for peripheral vascular malformations: the OVAMA projectS E R Horbach, C M A M van der Horst, F Blei, et al.
Journal of Natural Products|November 27, 2001
Macharistol, a new cytotoxic cinnamylphenol from the stems of Machaerium aristulatumE K Seo, N C Kim, Q Mi, et al.
Neuroimage. Clinical|August 5, 2016
Automated detection of cerebral microbleeds in patients with Traumatic Brain InjuryT L A van den Heuvel, A W van der Eerden, R Manniesing, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 27, 1999
Phase II trial of a paclitaxel and carboplatin combination in Asian patients with metastatic nasopharyngeal carcinomaE H Tan, K S Khoo, J Wee, et al.
Plos Genetics|October 4, 2008
A Myo6 mutation destroys coordination between the myosin heads, revealing new functions of myosin VI in the stereocilia of mammalian inner ear hair cellsRonna Hertzano, Ella Shalit, Agnieszka K Rzadzinska, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 3, 2014
Randomized, double-blind, placebo-controlled, multicenter phase II study of the efficacy and safety of apricoxib in combination with either docetaxel or pemetrexed in patients with biomarker-selected non-small-cell lung cancerMartin J Edelman, Ming T Tan, Mary J Fidler, et al.
Pageof 159